Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease


A global and diverse workforce

ThromboGenics employs around 80 people worldwide. Most of them work at our headquarters in Leuven (Belgium) or from our office in New Jersey (US).

The large majority of this international team holds a Master’s or PhD degree. All are united through their common goal: to make ThromboGenics a global leader in developing and commercializing innovative treatments for ophthalmic disorders.

The people who work at TG come from a variety of backgrounds that include different cultures, and different life and professional experiences. Many different and diverse minds coming together increases creativity and problem solving as every individual brings in their way of thinking, operating and solving problems. A diverse workforce strengthens our ability to respond to changing environments.

Equal Employment Opportunity and Non-Discrimination

ThromboGenics provides equal employment opportunities (“EEO”) to all employees and applicants for employment without regard to, and does not discriminate against any person on the basis of, race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, genetic information, marital status, amnesty or status as a covered veteran, or any other reason prohibited by law. This policy applies to all terms and conditions of employment, including hiring, placement, promotion, termination, layoff, recall, and transfer, leaves of absence, compensation and training.

Incubator for growth

Thanks to the dedication its people, ThromboGenics has grown considerably since it relocated from university labs to the BioIncubator Park in Leuven, Belgium, in 2009. To expand its global reach, drive innovation and achieve its strategic goals, ThromboGenics intends to further strengthen its team with new team members who have the right spirit and skillset.

Interested in joining the team?  Consult our jobsite and find out our job opportunities.